Trial Outcomes & Findings for Functional Dyspepsia Hypnosis (NCT NCT03884270)
NCT ID: NCT03884270
Last Updated: 2022-04-01
Results Overview
Feasibility will be calculated as the proportion of participants who complete the hypnotherapy treatment program in comparison to those who drop out before treatment is completed.
COMPLETED
NA
23 participants
12 weeks
2022-04-01
Participant Flow
Participant milestones
| Measure |
Hypnotherapy
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
Overall Study
STARTED
|
23
|
|
Overall Study
COMPLETED
|
22
|
|
Overall Study
NOT COMPLETED
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Functional Dyspepsia Hypnosis
Baseline characteristics by cohort
| Measure |
Hypnotherapy
n=23 Participants
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
Age, Continuous
|
38 years
STANDARD_DEVIATION 17 • n=5 Participants
|
|
Sex: Female, Male
Female
|
18 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic White/Caucasian
|
17 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic Black/African American
|
3 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic (any race)
|
2 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
23 participants
n=5 Participants
|
|
Relationship status
Single
|
7 Participants
n=5 Participants
|
|
Relationship status
Committed relationship
|
6 Participants
n=5 Participants
|
|
Relationship status
Married
|
10 Participants
n=5 Participants
|
|
Education
High school
|
3 Participants
n=5 Participants
|
|
Education
Some college
|
3 Participants
n=5 Participants
|
|
Education
Technical school or associates degree
|
2 Participants
n=5 Participants
|
|
Education
Undergraduate degree
|
8 Participants
n=5 Participants
|
|
Education
Some graduate school
|
1 Participants
n=5 Participants
|
|
Education
Graduate degree
|
6 Participants
n=5 Participants
|
|
Employment
Full-time
|
15 Participants
n=5 Participants
|
|
Employment
Part-time
|
2 Participants
n=5 Participants
|
|
Employment
Not working
|
4 Participants
n=5 Participants
|
|
Employment
Retired
|
2 Participants
n=5 Participants
|
|
Prior mental health diagnosis
Yes
|
11 Participants
n=5 Participants
|
|
Prior mental health diagnosis
No
|
12 Participants
n=5 Participants
|
|
Functional dyspepsia Rome Criteria met
Postprandial distress syndrome only
|
6 Participants
n=5 Participants
|
|
Functional dyspepsia Rome Criteria met
Epigastric pain syndrome only
|
2 Participants
n=5 Participants
|
|
Functional dyspepsia Rome Criteria met
Postprandial distress syndrome and epigastric pain syndrome
|
10 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 12 weeksPopulation: Participants enrolled in the study
Feasibility will be calculated as the proportion of participants who complete the hypnotherapy treatment program in comparison to those who drop out before treatment is completed.
Outcome measures
| Measure |
Hypnotherapy
n=23 Participants
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
Percent of Participants That Complete the Hypnotherapy Program
|
22 Participants
|
PRIMARY outcome
Timeframe: 12 weeksPopulation: Participants enrolled in the study and completed 3-month follow-up surveys.
Treatment satisfaction will be assessed with a single item at the end of treatment asking how satisfied they were overall with their assigned treatment (on a 7-point scale from "Extremely dissatisfied" to "Extremely satisfied")
Outcome measures
| Measure |
Hypnotherapy
n=22 Participants
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
Treatment Satisfaction
Extremely dissatisfied
|
1 Participants
|
|
Treatment Satisfaction
Very dissatisfied
|
0 Participants
|
|
Treatment Satisfaction
Somewhat dissatisfied
|
0 Participants
|
|
Treatment Satisfaction
Neutral
|
2 Participants
|
|
Treatment Satisfaction
Somewhat satisfied
|
12 Participants
|
|
Treatment Satisfaction
Very satisfied
|
4 Participants
|
|
Treatment Satisfaction
Extremely satisfied
|
3 Participants
|
PRIMARY outcome
Timeframe: 12 weeksPopulation: Participants enrolled in the study and completed 3-month follow-up surveys.
At the end of treatment, patients were asked an open-ended question to obtain feedback on their experience using the web-based platform for treatment. They were asked to rate their difficulty using the web platform on a 7-point scale from "Extremely difficult" to "Extremely easy".
Outcome measures
| Measure |
Hypnotherapy
n=22 Participants
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
Satisfaction With Web Platform
Extremely easy
|
17 Participants
|
|
Satisfaction With Web Platform
Moderately easy
|
3 Participants
|
|
Satisfaction With Web Platform
Somewhat easy
|
1 Participants
|
|
Satisfaction With Web Platform
Neutral
|
1 Participants
|
|
Satisfaction With Web Platform
Somewhat difficult
|
0 Participants
|
|
Satisfaction With Web Platform
Moderately difficult
|
0 Participants
|
|
Satisfaction With Web Platform
Extremely difficult
|
0 Participants
|
SECONDARY outcome
Timeframe: Baseline, 3-monthsPopulation: Participants enrolled in the study.
The PAGI-SYM is a 20-item self-report measure of functional dyspepsia symptom severity. The scale consists of 6 subscales (heartburn/regurgitation, nausea/vomiting, postprandial fullness/early satiety, bloating, upper abdominal pain, and lower abdominal pain). Each item is measured by a 6-point Likert scale ranging from 0 (no complaints) to 5 (severe complaints). Subscale scores are calculated by taking the mean of the items in each subscale. The total score is calculated by taking the mean of the subscale scores. Total scores range from 0 to 5, with higher scores indicating worse symptoms. The PAGI-SYM total score was regressed on the fixed effect of time period in a linear mixed effects regression model that included random intercepts to account for within-participant correlation. Least square mean differences were calculated as 3-month follow-up minus baseline.
Outcome measures
| Measure |
Hypnotherapy
n=23 Participants
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
The Patient Assessment of Upper Gastrointestinal Symptom Severity Index (PAGI-SYM) Will be Used to Assess Changes in Functional Dyspepsia Symptoms
|
-0.82 score on a scale
Standard Error 0.12
|
SECONDARY outcome
Timeframe: Baseline, 3 monthsPopulation: Participants enrolled in the study.
The NDI-SF is a 10-item self-report disease specific quality of life questionnaire. The scale consists of 5 sub-scales (tension/anxiety, interference with daily activities, disruption to regular eating/drinking, knowledge towards/control over disease, interference with work/study). Each item is measured by a 5-point Likert scale ranging from 0 (not applicable) to 4 (extremely). Individual items are aggregated to obtain a total score ranging from 0 to 100 with higher scores indicating greater impairment in quality of life. The NDI-SF score was regressed on the fixed effect of time period in a linear mixed effects regression model that included random intercepts to account for within-participant correlation. Least square mean differences were calculated as 3-month follow-up minus baseline.
Outcome measures
| Measure |
Hypnotherapy
n=23 Participants
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
The Short Form Nepean Dyspepsia Index (NDI-SF) Will be Used to Assess Changes in Quality of Life Related to Functional Dyspepsia.
|
-9.65 score on a scale
Standard Error 1.75
|
SECONDARY outcome
Timeframe: Baseline, 3 monthsPopulation: Participants enrolled in the study.
The VSI is a 15-item self-report questionnaire with responses ranging from 1 (strongly agree) to 6 (strongly disagree). The raw VSI score ranges from 0 (severe anxiety) to 75 (no anxiety). The VSI score was regressed on the fixed effect of time period in a linear mixed effects regression model that included random intercepts to account for within-participant correlation. Least square mean differences were calculated as 3-month follow-up minus baseline.
Outcome measures
| Measure |
Hypnotherapy
n=23 Participants
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
The Visceral Anxiety Index (VSI) Will be Used to Assess Changes in Gastrointestinal Specific Anxiety.
|
10.39 score on a scale
Standard Error 2.73
|
SECONDARY outcome
Timeframe: Baseline, 3 monthsPopulation: Participants enrolled in the study
The BSI is an 18-item self-report questionnaire with responses on a 5-point Likert scale, ranging from 0 (not bothered by a symptom at all) to 4 (extremely bothered). Three subscales are calculated (somatization, depression, and anxiety) and the subscales can be aggregated to calculate an overall global psychological distress score. The overall score and subscale scores are converted to T-scores (with a population mean of 50 and a standard deviation of 10). Higher T-scores indicate more psychological distress and T-scores ≥63 indicate clinically significant psychological distress. The BSI score was regressed on the fixed effect of time period in a linear mixed effects regression model that included random intercepts to account for within-participant correlation. Least square mean differences were calculated as 3-month follow-up minus baseline.
Outcome measures
| Measure |
Hypnotherapy
n=23 Participants
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
The Brief Symptom Inventory (BSI) Will be Used to Assess Changes in Psychological Distress.
|
-9.22 score on a scale
Standard Error 1.34
|
SECONDARY outcome
Timeframe: Baseline, 12 weeksPopulation: Participants enrolled in the study
At both baseline and end of treatment, patients will be asked to report the number of outpatient visits and procedures they have had within the last 3 months related to their functional dyspepsia symptoms
Outcome measures
| Measure |
Hypnotherapy
n=23 Participants
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
Changes in Outpatient Physician Consultation Following Hypnotherapy Treatment.
Number of outpatient visits at baseline
|
2 number of events
Interval 1.0 to 3.0
|
|
Changes in Outpatient Physician Consultation Following Hypnotherapy Treatment.
Number of outpatient visits at end of treatment
|
1 number of events
Interval 0.0 to 2.0
|
|
Changes in Outpatient Physician Consultation Following Hypnotherapy Treatment.
Number of procedures at baseline
|
2 number of events
Interval 1.0 to 2.0
|
|
Changes in Outpatient Physician Consultation Following Hypnotherapy Treatment.
Number of procedures at end of treatment
|
1 number of events
Interval 1.0 to 1.0
|
SECONDARY outcome
Timeframe: Baseline, 12 weeksPopulation: Participants enrolled in the study
At baseline and end of treatment, patients will be asked to report any medications they are taking related to their functional dyspepsia symptoms.
Outcome measures
| Measure |
Hypnotherapy
n=23 Participants
7 sessions of on-line hypnotherapy treatment over the course of 12 weeks (1 new session every 2 weeks)
Hypnotherapy: 7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia
|
|---|---|
|
Number of Medications Used for Functional Dyspepsia
Medications taking at baseline
|
1 number of medications
Interval 1.0 to 2.0
|
|
Number of Medications Used for Functional Dyspepsia
Medications taking at end of treatment
|
1 number of medications
Interval 1.0 to 2.0
|
Adverse Events
Hypnotherapy
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place